A POTENTIAL NEW TREATMENT IS BEING DEVELOPED. Connect your narcolepsy patients to our clinical trial and help create more options for your patients.

Avadel is seeking patients suffering from narcolepsy with cataplexy to enroll in the REST-ON trial, a phase 3 clinical trial evaluating investigational once-nightly sodium oxybate.

The REST-ON (Randomized study Evaluating the efficacy and SafeTy of a Once Nightly formulation of sodium oxybate) trial is a double-blind, randomized, placebo-controlled, two-arm, multicenter, phase 3 clinical trial evaluating FT218, an investigational extended-release oral suspension of sodium oxybate. This trial will assess the safety and efficacy of investigational sodium oxybate for the once-nightly treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.

Enrollment is open for patients aged 16 years or older with a current diagnosis of narcolepsy with cataplexy. Trial sites are available in the US, Canada, UK, Germany, France, Czech Republic, Finland, and Australia. If a patient is selected to participate in the trial, travel support is available based on their location.

For additional information on this clinical trial, please visit clinicaltrials.gov.

Your patients may be eligible to participate in the REST-ON trial if they:*

  • Have narcolepsy WITH cataplexy
  • Are 16 years of age or older
  • Have never been treated with sodium oxybate or have had very limited prior use

*Additional eligibility criteria applies.

Click below to refer patients who may meet these eligibility requirements. refer a patient now

The REST-ON clinical trial is an important step in advancing the range of treatment options available to your narcolepsy patients. By referring appropriate patients as possible participants, you are contributing to the development of potential new treatment options.

When referring a patient to the REST-ON clinical trial:

  • Once the form is submitted, you will be contacted by our clinical trial coordinator to discuss your patient’s eligibility
  • If your patient is prequalified to participate in the trial, you will be connected with the clinical investigator at the nearest site and required to participate in a conference call to discuss your patient
  • You will be compensated for the services you perform
Refer a patient now

There are REST-ON clinical trial sites located throughout the United States, Canada, Europe, and Australia. View the trial sites by location to determine which is closest to you. If a patient is selected to participate in the trial, travel support is available based on their location.


Do you have colleagues who may be interested in referring patients to the REST-ON trial?
Ask them to visit restontrial.com to learn more.